This study revealed that ALKBH5 increases glycolysis in drug-resistant breast cancer cells by promoting m6A demethylation of GLUT4 messenger RNA (mRNA), thereby increasing GLUT4 expression[31]. This evidence concerns the gene SLC2A4 and breast cancer.